genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX 1.250
+0.025 (2.04%)
May 28, 2026, 4:29 PM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 19.67 million as of May 28, 2026. Its market cap has increased by 125.78% in one year.
Market Cap
19.67M
Enterprise Value
19.78M
Revenue
1.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.25
Market Cap Chart
Since April 10, 2007, genedrive's market cap has increased from 11.67M to 19.67M, an increase of 68.53%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 19.67M | 118.32% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.52B |
| GSK plc | 76.85B |
| Haleon | 30.29B |
| Smith & Nephew | 9.72B |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 19.87M |
| IXICO | 19.08M |
| CelLBxHealth | 18.47M |